Innovations in radical cystectomy and pelvic lymph node dissection.

Area of Science:

• Urology
• Surgical Oncology

Background:

• Radical cystectomy with bilateral pelvic lymphadenectomy is the gold standard for muscle-invasive urothelial carcinoma of the bladder.
• Optimal locoregional cancer control is achieved with perioperative cisplatin-based chemotherapy.

Purpose of the Study:

• To review advancements in surgical techniques, preoperative staging, and perioperative care for bladder cancer.
• To highlight the role of minimally invasive approaches, such as robot-assisted radical cystectomy.

Main Methods:

• Review of current literature on radical cystectomy and lymphadenectomy for urothelial carcinoma.
• Discussion of preoperative staging, neoadjuvant chemotherapy, and surgical innovations.

Main Results:

• Improved preoperative staging aids in identifying candidates for neoadjuvant chemotherapy and neobladder reconstruction.
• Minimally invasive techniques and enhanced perioperative care minimize morbidity and preserve function.
• Anatomic lymphadenectomy is vital for accurate staging and potentially improving survival.

Conclusions:

• Radical cystectomy with pelvic lymphadenectomy, combined with chemotherapy, remains the cornerstone of treatment.
• Surgical innovations and improved staging enhance oncologic control and patient outcomes.
• Minimally invasive radical cystectomy shows promise in urologic surgery.